Mb. Oconnell, PHARMACOKINETIC AND PHARMACOLOGICAL VARIATION BETWEEN DIFFERENT ESTROGEN PRODUCTS, Journal of clinical pharmacology, 35(9), 1995, pp. 18-24
Due to the complex nature of endogenous and exogenous hormone concentr
ations, formation, and metabolism and assay complexity, the pharmacoki
netics of estrogens are difficult to study. Oral estrogens have minima
l systemic bioavailability (2% to 10%) due to gut and liver (first-pas
s) metabolism. High concentrations of estrone are achieved with oral a
dministration, whereas higher concentrations of estradiol are generall
y achieved after percutaneous absorption. Although vaginal products (s
uch as gel, rings, etc.) are administered locally, they achieve high s
erum concentrations. Estradiol and estrone concentrations and estradio
l-to-estrone ratios vary with different estrogen therapies. Approximat
ely 95% to 98% of estradiol is bound loosely to albumin or tightly to
sex hormone binding globulin, the major binding protein. The terminal
half lives for the different estrogen compounds (after oral or intrave
nous administration) vary from 1-12 hours. Some conversion rates have
been calculated between estrogen and its metabolites. Smoking decrease
s achievable estrogen concentrations, and has a greater effect on oral
products. Oral contraceptives have been found to decrease antipyrine
clearance. In the one study evaluating conjugated estrogens, antipyrin
e clearance was not altered. Oral contraceptives have a variable effec
t on the elimination of medications. Acetaminophen clearance is increa
sed, whereas clearance of some benzodiazepines, caffeine, and predniso
lone is decreased. Phenytoin increases the metabolism of conjugated es
trogens. The various estrogen products may produce different clinical
effects based on composition. The metabolites (minor components) of co
njugated estrogens have been found to have significant effects on lipi
d concentrations, uterine weight, liver generated compounds, and bone
resorption. Because transdermal products bypass the first-pass effect,
delayed or decreased effects on lipid profiles and liver generated co
mpounds have been observed.